Bormann-Kennedy Barbara-Jean Anne

Bormann-Kennedy Barbara-Jean Anne is listed in filings as Director at Xeris Biopharma Holdings, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Xeris Biopharma Holdings, Inc. (XERS). The current snapshot covers public activity from Jun 4, 2025 to Jun 5, 2026. Reported amounts are shown as $202.9K to $106.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.